# Apodex 1.1 vs Nemotron 3.5 Bolt E4B BF16

> Side-by-side benchmark comparison for Apodex 1.1 and Nemotron 3.5 Bolt E4B BF16 across agentic, coding, multimodal, knowledge, reasoning, multilingual, and math tasks.

- Canonical page: https://benchlm.ai/compare/apodex-1-1-vs-nemotron-3-5-bolt-e4b-bf16
- Last updated: October 23, 2026

- Shared sourced benchmarks: 0
- HTML indexing: indexable
- Ranking lane: BenchAlign v5.8

## Quick Verdict

No benchmark verdict yet: there is no shared sourced benchmark row for Apodex 1.1 and Nemotron 3.5 Bolt E4B BF16.

## Summary

- Apodex 1.1 and Nemotron 3.5 Bolt E4B BF16 do not currently share a sourced benchmark row. The mirror therefore compares metadata, pricing, context windows, and each model's separately reported coverage without naming a benchmark winner.

## Model Snapshot

| Property | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 |
|----------|----------|----------|
| Creator | Apodex | NVIDIA |
| Type | Proprietary | Open Weight |
| Reasoning | Reasoning | Reasoning |
| Context | N/A | 64K |
| Independent public score (not head-to-head) | 50.17 | null |
| Benchmarks Covered | 10 | 19 |
| Pricing (input/output) | Pricing unavailable / Pricing unavailable | Pricing unavailable / Pricing unavailable |

## Category Breakdown

### Agentic

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 46.8 (Estimated · #57/132)
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| HLE w/ tools | 56.1% | Coming soon | Coming soon |
| APEX-Agents | 38.5% | Coming soon | Coming soon |
| DeepSearchQA | 92.4% | Coming soon | Coming soon |
| BFCL v3 | Coming soon | 68.5% | Coming soon |
| When2Call Multi-Turn | Coming soon | 63.36% | Coming soon |
| ToolSandbox | Coming soon | 68.77% | Coming soon |
| τ²-bench results | Coming soon | 55.1% | Coming soon |
| RelyToolBench | Coming soon | 63.16% | Coming soon |

### Coding

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 42.1 (Estimated · #63/153)
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| Terminal-Bench 2.1 | 70.8% | Coming soon | Coming soon |
| SWE-bench Verified | 77.7% | Coming soon | Coming soon |

### Reasoning

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 79.5 (Unranked · 2 rankable rows)
- Nemotron 3.5 Bolt E4B BF16 public-lane score: 29 (Unranked · 1 rankable row)

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| RULER (64K) | Coming soon | 86.99% | Coming soon |
| LongMemEval | Coming soon | 72.10% | Coming soon |
| LongBench v2 | Coming soon | 50.5% | Coming soon |

### Multimodal & Grounded

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 82.1 (Unranked · 1 rankable row)
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

### Knowledge

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: 55 (Supported · #56/187)
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| HLE | 56.1% | Coming soon | Coming soon |
| FrontierScience Research | 63.3% | Coming soon | Coming soon |
| BioMysteryBench (human-difficult) | 35.3% | Coming soon | Coming soon |
| GaRAGe | Coming soon | 42.61% | Coming soon |
| RAGTruth (provider reports) | Coming soon | 77.59% | Coming soon |

### Instruction Following

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| MultiChallenge (provider reports) | Coming soon | 53.10% | Coming soon |
| Brevity Benchmark | Coming soon | 82.52% | Coming soon |
| RoleBench | Coming soon | 67.05% | Coming soon |
| RoleMRC | Coming soon | 80.63% | Coming soon |
| IHEval | Coming soon | 84.79% | Coming soon |
| AgentIF | Coming soon | 25.81% | Coming soon |
| InverseIFEval | Coming soon | 46.84% | Coming soon |
| StructEval-T | Coming soon | 80.40% | Coming soon |
| SysBench | Coming soon | 67.88% | Coming soon |

### Mathematics

- Winner: Insufficient shared evidence
- Apodex 1.1 public-lane score: Coming soon
- Nemotron 3.5 Bolt E4B BF16 public-lane score: Coming soon

| Benchmark | Apodex 1.1 | Nemotron 3.5 Bolt E4B BF16 | Winner |
|-----------|-----------|-----------|--------|
| IMO 2026 | 31/42 | Coming soon | Coming soon |

## FAQ

### Can I compare Apodex 1.1 and Nemotron 3.5 Bolt E4B BF16 on BenchLM yet?

Not fully yet. BenchLM is tracking both models, but sourced benchmark coverage is still incomplete for a fair score-level comparison.

### Why does this page show "coming soon" values?

BenchLM only calls winners when public benchmark coverage is available on both sides of the comparison.

## Related Comparisons

- [Apodex 1.1 vs Apodex 1.1 Mini](/compare/apodex-1-1-vs-apodex-1-1-mini)
- [Nemotron 3.5 Bolt E4B BF16 vs Apodex 1.1 Mini](/compare/apodex-1-1-mini-vs-nemotron-3-5-bolt-e4b-bf16)
- [Apodex 1.1 vs Nemotron 3.5 Bolt E4B](/compare/apodex-1-1-vs-nemotron-3-5-bolt-e4b)
- [Nemotron 3.5 Bolt E4B BF16 vs Nemotron 3.5 Bolt E4B](/compare/nemotron-3-5-bolt-e4b-vs-nemotron-3-5-bolt-e4b-bf16)

## Explore More

- [Apodex 1.1 profile](/models/apodex-1-1)
- [Nemotron 3.5 Bolt E4B BF16 profile](/models/nemotron-3-5-bolt-e4b-bf16)
- [Compare Pricing](/llm-pricing)
- [Alternative Finder](/tools/alternative-finder)
- [LLM Selector](/tools/llm-selector)
- [Overall Rankings](/best/overall)